只使用免费官方源:SEC Forms 3/4/5 结构化内部人申报,以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界,不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量;个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S(公开市场或私下交易),成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-06 2026-07-06 | ALKS Alkermes plc. | Gaffin David Joseph Officer · EVP, CLO, Alkermes, Inc. | 卖出(S) | 2,034 | US$54.03 | US$109,897.02 | 227,490 | SEC |
| 2026-07-01 2026-07-01 | ALKS Alkermes plc. | Hopkinson Craig C. Officer · EVP R&D, Chief Medical Officer | 卖出(S) | 8,300 | US$51.46 | US$427,128.79 | 74,089 | SEC |
| 2026-07-01 2026-07-01 | ALKS Alkermes plc. | Hopkinson Craig C. Officer · EVP R&D, Chief Medical Officer | 卖出(S) | 700 | US$52.13 | US$36,491.98 | 73,389 | SEC |
| 2026-06-18 2026-06-22 | TALK Talkspace, Inc. | Reilly John Charles Officer · Chief Legal Officer, Secretary | 卖出(S) | 700 | US$5.21 | US$3,647.00 | 1,017,686 | SEC |
| 2026-06-18 2026-06-22 | TALK Talkspace, Inc. | Reilly John Charles Officer · Chief Legal Officer, Secretary | 卖出(S) | 474 | US$5.21 | US$2,469.54 | 1,018,386 | SEC |
| 2026-06-18 2026-06-22 | TALK Talkspace, Inc. | Reilly John Charles Officer · Chief Legal Officer, Secretary | 卖出(S) | 39,115 | US$5.20 | US$203,398.00 | 1,018,860 | SEC |
| 2026-06-12 2026-06-16 | TALK Talkspace, Inc. | Reilly John Charles Officer · Chief Legal Officer, Secretary | 卖出(S) | 900 | US$5.22 | US$4,698.00 | 1,112,219 | SEC |
| 2026-06-12 2026-06-16 | TALK Talkspace, Inc. | Reilly John Charles Officer · Chief Legal Officer, Secretary | 卖出(S) | 54,244 | US$5.21 | US$282,611.24 | 1,057,975 | SEC |
| 2026-06-12 2026-06-12 | ALKS Alkermes plc. | Wright Christopher I Director | 卖出(S) | 2,000 | US$45.10 | US$90,200.00 | 25,680 | SEC |
| 2026-06-04 2026-06-04 | ALKS Alkermes plc. | Gaffin David Joseph Officer · EVP, CLO, Alkermes, Inc. | 卖出(S) | 2,034 | US$43.05 | US$87,563.70 | 229,524 | SEC |
| 2026-06-01 2026-06-01 | ALKS Alkermes plc. | Hopkinson Craig C. Officer · EVP R&D, Chief Medical Officer | 卖出(S) | 9,000 | US$41.67 | US$375,030.00 | 77,389 | SEC |
| 2026-05-29 2026-05-29 | ALKS Alkermes plc. | Parisi Samuel Joseph Officer · VP, Finance (Interim PAO) | 卖出(S) | 16,217 | US$42.36 | US$686,952.12 | 7,717 | SEC |
| 2026-05-04 2026-05-04 | ALKS Alkermes plc. | Gaffin David Joseph Officer · EVP, CLO, Alkermes, Inc. | 卖出(S) | 2,034 | US$33.20 | US$67,528.80 | 231,558 | SEC |
| 2026-05-01 2026-05-01 | ALKS Alkermes plc. | Hopkinson Craig C. Officer · EVP R&D, Chief Medical Officer | 卖出(S) | 9,000 | US$33.40 | US$300,600.00 | 81,389 | SEC |
| 2026-04-06 2026-04-06 | ALKS Alkermes plc. | Gaffin David Joseph Officer · EVP, CLO, Alkermes, Inc. | 卖出(S) | 2,034 | US$34.57 | US$70,315.38 | 233,592 | SEC |
| 2026-04-01 2026-04-01 | ALKS Alkermes plc. | Hopkinson Craig C. Officer · EVP R&D, Chief Medical Officer | 卖出(S) | 9,000 | US$35.51 | US$319,590.00 | 85,389 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| ALKS | 315,343.9496 | 0 | 586,768.4793 | 53.74% | B, Q, N |